All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of smooth muscle cell proliferation | GO_0048661 |
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
| positive regulation of cell population proliferation | GO_0008284 |
Any process that activates or increases the rate or extent of cell proliferation.
|
| regulation of smooth muscle cell proliferation | GO_0048660 |
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
|
| isoleucine biosynthetic process | GO_0009097 |
The chemical reactions and pathways resulting in the formation of isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
|
| isoleucine metabolic process | GO_0006549 |
The chemical reactions and pathways involving isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
|
| negative regulation of smooth muscle cell proliferation | GO_0048662 |
Any process that stops, prevents or reduces the rate or extent of smooth muscle cell proliferation.
|
| leucine biosynthetic process | GO_0009098 |
The chemical reactions and pathways resulting in the formation of leucine, 2-amino-4-methylpentanoic acid.
|
| leucine metabolic process | GO_0006551 |
The chemical reactions and pathways involving leucine, 2-amino-4-methylpentanoic acid.
|
| GO_0009096 | GO_0009096 | |
| RNA strand-exchange activity | GO_0034057 |
Facilitates the displacement of one strand of an RNA-RNA duplex and its replacement with a different strand of higher complementarity.
|
| single-stranded RNA binding | GO_0003727 |
Binding to single-stranded RNA.
|
| double-stranded RNA binding | GO_0003725 |
Binding to double-stranded RNA.
|
| endosomal vesicle fusion | GO_0034058 |
The homotypic fusion of endocytic vesicles to form or add to an early endosome.
|
| valine biosynthetic process | GO_0009099 |
The chemical reactions and pathways resulting in the formation of valine, 2-amino-3-methylbutanoic acid.
|
| valine metabolic process | GO_0006573 |
The chemical reactions and pathways involving valine, 2-amino-3-methylbutanoic acid.
|
| effector-mediated induction of programmed cell death in host | GO_0034055 |
A symbiont process in which a molecule secreted by the symbiont activates a programmed cell death pathway in the host to suppress the host innate immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
| suppression by symbiont of host innate immune response | GO_0052170 |
Any process in which a symbiont stops, prevents, or reduces the frequency, rate or extent of the innate immune response of the host organism, the host's first line of defense against infection. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
| effector-mediated modulation of host process by symbiont | GO_0140418 |
A process mediated by a molecule secreted by a symbiont that results in the modulation (either activation or suppresion) of a host structure or process. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
| modulation by symbiont of host defense-related programmed cell death | GO_0034053 |
Any process in which a symbiont modulates the frequency, rate or extent of defense-related programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
| positive regulation by symbiont of host programmed cell death | GO_0052042 |
Any process in which an organism activates, maintains or increases the frequency, rate or extent of programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
|